4/A//SEC Filing
Patel Gautam 4/A
Accession 0000898432-23-000827
CIK 0001723128other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:15 PM ET
Size
5.8 KB
Accession
0000898432-23-000827
Insider Transaction Report
Form 4/AAmended
Patel Gautam
Director
Transactions
- Other
Class A Common Stock
2021-12-01+3,073,298→ 15,960,731 total(indirect: Footnote)
Footnotes (2)
- [F1]On December 1, 2021, an entity controlled by the reporting person was designated as the trustee of a trust that holds 3,073,298 shares of the Class A Common Stock of the issuer. These shares were not previously reported as being beneficially owned by the reporting person due to a clerical error. The reporting person is filing this amendment to the Form 4 filed on December 20, 2021, to include the shares held by the trust in the number of shares reported as being beneficially owned by the reporting person through trusts which the reporting person may be deemed to control. As a result of the error, all Section 16 reports filed by the reporting person after December 20, 2021 understated the number of shares of the Class A Common stock of the issuer beneficially owned by the reporting person by 3,073,298 shares. All such subsequent reports are hereby updated by this amendment.
- [F2]By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001738054
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:15 PM ET
- Size
- 5.8 KB